A Study of Terbium 161 (161Tb)-RAD402 in Participants With CRPC

Clinical trial NCT07259213 · RECRUITING

Trial details

NCT number: NCT07259213
Sponsor: Radiopharm Theranostics, Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Castration-resistant Prostate Cancer

Start date: 2026-03-05
Primary completion: 2028-11-30
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.